July 6, 2022
Astellas Pharma and UK biopharma Mogrify said on July 5 that they have sealed a research collaboration pact on in vivo regenerative medicine approaches to address sensorineural hearing loss. No financial terms of the deal were disclosed. The collaboration will...read more